These findings indicate that STAT1 and STAT3 are activated during replicative senescence and that Bar treatment effectively inhibits the JAK1/2-STAT1/3 signaling axis in both normal and HGPS cells. This evidence concerns the gene STAT3 and Hutchinson-Gilford progeria syndrome.